# Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)

> **NCT02959853** · PHASE4 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 23 (actual)

## Conditions studied

- Hypogonadism
- Severe Obesity

## Interventions

- **DRUG:** Anastrazole
- **BEHAVIORAL:** weight loss

## Key facts

- **NCT ID:** NCT02959853
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-11-20
- **Final completion:** 2018-12-20
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02959853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02959853, "Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02959853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*